Nxera Pharma is headquartered in Minato, Japan.
Nxera Pharma disclosed revenue of 28,835M JPY for 2024 and 12,766M JPY for 2023.
Nxera Pharma has 389 employees.
Nxera Pharma is a life science company.
Nxera Pharma was founded in 1990.
Midtown East 9-7-2 Akasaka,
Minato,
107-0052
Japan,
+81 3 5962 5718
www.nxera.life
Nxera Pharma is a biopharmaceutical company. Nxera Pharma’s primary business model is based on identifying novel and/or differentiated product assets or technology platforms and, through supporting these in preclinical and clinical development and establishing commercial partnerships, advancing new medicines to patients worldwide. Nxera Pharma was founded in 1990 and is based in Minato, Japan.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| vol | $400M | $400M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
| Financial | Deals |
|---|---|
|
Moelis & Co. |
1 |
| Legal | Deals |
|---|---|
|
Clifford Chance |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
